QVQ contributes to the accurate and sensitive detection of diseases in the early stages by providing top quality validated Imaging and Research Agents based on their C-Direct labeled single domain antibodies from camelids (professionally called functionalized VHH). To become a supplier of top-end market products, QVQ closely works together with top academic and industrial groups and actively stimulates research in these areas.
View Top Employees from QVQ Holding BVWebsite | http://www.qvquality.com |
Revenue | $5.3 million |
Employees | 21 (20 on RocketReach) |
Founded | 2010 |
Phone | +31 30 253 3421 |
Technologies |
JavaScript,
HTML,
PHP
+9 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services |
Web Rank | 35 Million |
Keywords | Qvq |
Competitors | Aptus Biotech, International Therapeutics Inc, Isogenica Limited, ManRos Therapeutics, Morphic Therapeutic |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular QVQ Holding BV employee's phone or email?
The QVQ Holding BV annual revenue was $5.3 million in 2024.
20 people are employed at QVQ Holding BV.
The NAICS codes for QVQ Holding BV are [5417, 541, 541713, 54, 54171].
The SIC codes for QVQ Holding BV are [873, 87].